At a cost of around *** thousand U.S. dollars, heart valve replacements were among the most expensive surgeries in the United States as of 2021. Other surgeries that cost over 100 thousand U.S. dollars at that time included bypass surgery and spinal fusion surgery. However, these prices are not complete because they do not include airfare travel or lodging costs for the patient (and companion). On the other hand, there might be variations due to factors like type of hospital, doctor’s experience, accreditation, currency exchange rates, etc. Higher health care costs in the U.S. Increasing health care costs in the U.S. are driven by many things, but the increased use of technology is a strong driver of rising health care costs. The electrosurgical segment of the surgical instrument market has grown in recent years and is expected to continue to grow. Other forms of medical technology are also on the rise, such as forms of digital health, electronic medical records, and diagnostics. The U.S. digital health market has grown and is expected to see significant gains in the coming years. Heart surgeries Some of the most frequent operations performed in the U.S. include cesarean sections, arthroplasty of the knee and percutaneous coronary angioplasty. The cost of heart bypass surgeries in the U.S. is significantly higher than the cost of bypass surgeries in other countries around the world. It is projected that the cost of treating coronary heart disease will exceed the cost of treating many other cardiovascular diseases. The cost increase is clearly seen in the increase in surgical treatment prices. Since 2005, the cost of a coronary angioplasty surgical treatment in the U.S. has nearly doubled.

The graph displays the costs of various surgeries without insurance in the United States for the year 2021. The x-axis represents different surgical procedures—including Heart Valve Replacement, Heart Bypass, Spinal Fusion, Hip Replacement, and others—while the y-axis indicates the price in dollars for each procedure. Prices vary widely, ranging from a low of $1,000 for Lasik surgery (both eyes) to a high of $170,000 for a Heart Valve Replacement. The data reveals that more complex and critical procedures like Heart Valve Replacement and Heart Bypass are significantly more expensive than elective surgeries such as Rhinoplasty and Breast Implants. This highlights the substantial variation in surgical costs depending on the type and complexity of the procedure.

In 2024, facelifts, lower body lifts, and tummy tucks (abdominoplasty) were among the ************** plastic surgery procedures in the United States. That year, the average surgeon fees for a facelift in the U.S. was somewhere between ****** and *******U.S. dollars.

In 2022, the price for a cataract surgery stood at some 2,224 U.S. dollars in the United States, which is roughly the median compared to other countries. However, the U.S. has consistently the highest prices among comparison countries when it comes to inpatient hospital procedures.

This data package contains the Information including the U.S. national trends in the number of inpatient stays, Healthcare Resource Group (HRG) unit costs for acute hospital procedures, Medicare Inpatient Prospective Payment System (IPPS) for discharges costs, Ambulatory Payment Classification (APC) Groups, Short-Stay Hospitals discharges information for Aged Beneficiaries, All Beneficiaries, Information on Office visit per Medicare beneficiaries and hospitalization counts and rates.

The median cost for coronary bypass surgery in a hospital in the United States was ****** U.S. dollars in 2022. This was more than five times the price in Germany. Meanwhile, in Austria, a coronary bypass surgery cost just ****** U.S. dollars, the least expensive among these countries.

This database provides the 2011 average costs of hospital stays in medicine, surgery, obstetrics and odontology (MCO) in private health facilities. This benchmark is in the form of a cost scale organised according to the classification (v11e) of homogeneous groups of patients (GHM). The average costs were calculated on the basis of data from the National Common Methodology Cost Study (ENCC) for the 2011 activity. This benchmark was developed from a sample of 73 health facilities, rectified with national data collected by the Medical Information Systems Program (PMSI). In addition to access to the detailed bases of average costs, it is possible to consult summary sheets according to different categories of activity: major diagnostic category (CMD), sub-CMD, root and GHM. On these fiches, the cost developments compared to the financial year 2010 are specified. A summary document “Main results from the 2011 benchmark” details the main results of the cost data assessed from the 2011 data and their evolution compared to 2010. After a general presentation, the results are analysed by CMD, activity, severity levels, etc. In addition, two guides make it easier to read and understand this information: — ‘Practical Reference Guide 2011’, which lists the detailed data of the repository and explains the access to the data and the use of the various tabs; — ‘Referential Technical Guide 2011’, which sets out the methods for calculating the average cost and the associated statistical indicators.

The day case surgery market is experiencing robust growth, driven by several key factors. Technological advancements in minimally invasive surgical techniques, such as laparoscopy and robotic surgery, are significantly reducing recovery times and enabling more procedures to be performed on an outpatient basis. Simultaneously, increasing demand for cost-effective healthcare solutions is pushing both patients and providers towards day case surgeries, which typically have lower overall costs compared to inpatient procedures. The preference for shorter hospital stays, quicker return to normal activities, and reduced risk of hospital-acquired infections further contributes to the market's expansion. This trend is particularly evident in high-income countries with well-developed healthcare infrastructure, where the adoption of advanced surgical technologies is prevalent. We estimate the market size in 2025 to be $150 billion, based on the prevalence of these procedures globally and extrapolation from publicly available reports on related medical markets, considering factors like procedure volume and average cost per procedure. Assuming a conservative CAGR of 7% (typical of the healthcare sector and accounting for potential market saturation in certain regions), we project continued growth over the forecast period (2025-2033). However, the market growth isn't without challenges. Regulatory hurdles related to patient safety and the need for specialized facilities equipped to handle day case surgeries can pose obstacles to expansion in some regions. Furthermore, the uneven distribution of healthcare resources across geographical areas can restrict access to these procedures in underserved communities. Despite these constraints, the long-term outlook remains positive, with the continued development of less-invasive surgical techniques and a growing emphasis on patient-centric care projected to sustain market growth. The leading players in this market, including Mayo Clinic, Massachusetts General Hospital, and others listed, are investing heavily in expanding their capacity for day case procedures, strengthening their market positions, and driving innovation within the sector. The competition is likely to increase and consolidate in the years to come.

Pursuant to the Utah Health Data Authority Act, Section 106 (UCA 26-33a-106.5), the Office of Health Care Statistics (OHCS) has produced a list common medical procedures and their associated costs for Utah's commercially-insured market, using the state's All Payer Claims Database (APCD).The 25th, 50th, 75th and average charged and allowed amount percentiles will be displayed for both line items and claim headers (entire claim cost).

The analysis breaks the claims into groupings based on the Health Care Cost Institute methodology.

Flags are created to identify professional or technical components as well as an assistant surgeon indicator. Additionally, place of service codes are used to classify professional claims as facility or non-facility categories.

Please see methodology further information.

This dataset contains information submitted by New York State Article 28 Hospitals as part of the New York Statewide Planning and Research Cooperative (SPARCS) and Institutional Cost Report (ICR) data submissions. The dataset contains information on the volume of discharges, All Payer Refined Diagnosis Related Group (APR-DRG), the severity of illness level (SOI), medical or surgical classification the median charge, median cost, average charge and average cost per discharge. When interpreting New York’s data, it is important to keep in mind that variations in cost may be attributed to many factors. Some of these include overall volume, teaching hospital status, facility specific attributes, geographic region and quality of care provided. For more information, check out: http://www.health.ny.gov/statistics/sparcs/ or go to the "About" tab.

Weighted average procedure costs, follow-up costs, subsequent retreatment costs, periprocedural AE costs, short- and long-term AE costs.

In 2023, among minimally invasive cosmetic procedures in the United States, the most expensive was ****************************. That year, the average cost of came to ***** U.S. dollars in the U.S. While Botox and co. (neuromodulator injections) were the most popular minimally invasive procedures, it was also the ***************, most likely the reason for the popularity.

These are peer-reviewed supplementary materials for the article 'Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims' published in the Journal of Comparative Effectiveness Research.Figure A1: Comparison of study complication rates to the ACS NSQIP risk calculator average risk of any complication for the procedures of interest.Table A1: Summary of covariates, full dataset and matched dataset. Table A2: Matched dataset balance diagnostics. Standardized mean differences. No complications (control) versus complications.Table A3: Procedures and diagnoses (i.e., complications) groups, ICD10 codes and countsTable A4: Comparison of Study complication rates to ACS NSQIP average risk of any and serious complicationsAim: To compare the length of stay, hospital costs and hospital revenues for Medicare patients with and without a subset of potentially preventable postoperative complications after major noncardiac surgery. Materials & methods: Retrospective data analysis using the Medicare Standard Analytical Files, Limited Data Set, 5% inpatient claims files for years 2016–2020. Results: In 74,103 claims selected for analysis, 71,467 claims had no complications and 2636 had one or more complications of interest. Claims with complications had significantly longer length of hospital stay (12.41 vs 3.95 days, p < 0.01), increased payments to the provider ($34,664 vs $16,641, p < 0.01) and substantially higher estimates of provider cost ($39,357 vs $16,158, p < 0.01) compared with claims without complications. This results on average in a negative difference between payments and costs for patients with complications compared with a positive difference for claims without complications (-$4693 vs $483, p < 0.01). Results were consistent across three different cost estimation methods used in the study. Conclusion: Compared with patients without postoperative complications, patients developing complications stay longer in the hospital and incur increased costs that outpace the increase in received payments. Complications are therefore costly to providers and payers, may negatively impact hospital profitability, and decrease the quality of life of patients. Quality initiatives aimed at reducing complications can be immensely valuable for both improving patient outcomes and hospital finances.

Service to search for non-covered treatment cost information of hospital-level or higher medical institutions managed by the Health Insurance Review & Assessment Service - Non-covered item code information: Non-covered code (person), medium classification code (person), small classification code (person), detailed classification code (person), application start date, application end date - Non-covered item hospital list: Encrypted treatment symbol, hospital name, type code (person), treatment institution location, non-covered code (person), application start date, application end date, minimum price, maximum cost - Non-covered treatment cost type information: Non-covered code (person), application start date, maximum/minimum/average/median cost by type - Non-covered treatment cost region information: Non-covered code (person), application start date, total maximum cost, maximum/minimum/average/median cost by region

Percent change in hospitalization cost following EC-IC bypass surgery for the variables included in the final predictive model.

This retrospective study examined treatment characteristics and the economic burden associated with rotator cuff tears (RCT) and rotator cuff repairs (RCR). Additionally, this study aimed to explore the economic implications associated with delayed surgical intervention. Adult RCT patients meeting eligibility criteria were identified from 1/1/2013–6/30/2017 using the IBM Watson Health MarketScan Commercial database. Patients with incident RCR within 12 months post-index and 12 months continuous enrollment after the RCR date were also analyzed. Early surgery was defined as RCR within 6 months and 1 month from the partial-thickness tear and full-thickness tear diagnoses, respectively. Patient characteristics, all-cause direct costs (plan paid and patient out-of-pocket), RCT-related costs, pre-surgical costs, post-surgical costs, and healthcare resource utilization were reported by RCT type. Attributable indirect costs, absenteeism and short-term disability (STD), were also estimated. 102,488 RCT patients were identified (partial-thickness tears: 46,856 [45.7%]; full-thickness tears: 55,632 [54.3%]). Fifty per cent RCT patients underwent RCR within 12-months of diagnosis. Full-thickness RCT patients had an average total baseline (one year pre-diagnosis) and post-index costs of $17,096 and $32,110, respectively. Similarly, partial thickness patients had baseline costs of $16,385 and post-index costs of $27,017. Mean all-cause annual post-surgery costs were $34,086 for patients with partial-thickness tears and $34,249 for patients with full-thickness tears, of which 40% and 38% of costs were RCT-related, respectively. Productivity losses due to absenteeism and STD in the 12-month post-surgery period averaged $5843 and $4493, respectively, for partial-thickness tear patients and $5770 and $4382, respectively, for full-thickness tear patients. Average additional spending per delayed surgical patient between diagnosis and surgery was $8524 and $3213 (both p 

Cost transparency is important to facilitate national health infrastructure planning for pediatric cardiac surgery in low-resourced settings. The aim of this paper is to determine direct medical costs of common pediatric congenital heart procedures performed by an in-house cardiac surgery program in Rwanda. Billing information for patients with isolated congenital heart disease who underwent surgery between October 2022 and April 2024 was collected from the hospital management system. Charges were organized into 10 categories, including procedure cost, theater medications and consumables, intensive care unit and ward expenses, anesthesia fees, hospital charges, room charges, testing, and ancillary services. Linear regression was performed to identify perioperative factors associated with increased costs. Costs were converted from Rwandan Francs to US Dollars using the exchange rate 1 USD = 1,262 RWF on 1 January 2024. 117 patients received 8 types of surgeries. Median costs ranged from USD$1,969.04 for patent ductus arteriosus ligation to USD$18,239.00 for arterial switch operation. Excluding the latter, the cost of surgeries was USD$7,662 or less. Theater medications and consumables were the most expensive category accounting for 44.6% (USD$3,071.28) of total costs. This was followed by the cost of cardiothoracic procedure itself which constituted 15.4% (USD$810.90) of total costs. Prolonged hospital stays and operative times increased costs by USD$172.57 and USD$1,015.35 (p < 0.001), respectively. Complications and lesion complexity did not independently predict increased costs (p > 0.05). Direct medical costs of pediatric congenital heart surgeries in Rwanda are generally lower than the mean USD$7,366 plus travel expenses charged abroad. Costs can be lowered by reducing per unit costs of theater consumables and ensuring timely discharge.

This dataset contains information submitted by New York State Article 28 Hospitals as part of the New York Statewide Planning and Research Cooperative (SPARCS) and Institutional Cost Report (ICR) data submissions. The dataset contains information on the volume of discharges, All Payer Refined Diagnosis Related Group (APR-DRG), the severity of illness level (SOI), medical or surgical classification the median charge, median cost, average charge and average cost per discharge. When interpreting New York’s data, it is important to keep in mind that variations in cost may be attributed to many factors. Some of these include overall volume, teaching hospital status, facility specific attributes, geographic region and quality of care provided. For more information, check out: http://www.health.ny.gov/statistics/sparcs/ or go to the "About" tab.

IntroductionThis study aimed to estimate the direct medical costs and out-of-pocket (OOP) expenses associated with inpatient and outpatient care for IHD, based on types of health insurance. Additionally, we sought to identify time trends and factors associated with these costs using an all-payer health claims database among urban patients with IHD in Guangzhou City, Southern China.MethodsData were collected from the Urban Employee-based Basic Medical Insurance (UEBMI) and the Urban Resident-based Basic Medical Insurance (URBMI) administrative claims databases in Guangzhou City from 2008 to 2012. Direct medical costs were estimated in the entire sample and by types of insurance separately. Extended Estimating Equations models were employed to identify the potential factors associated with the direct medical costs including inpatient and outpatient care and OOP expenses.ResultsThe total sample included 58,357 patients with IHD. The average direct medical costs per patient were Chinese Yuan (CNY) 27,136.4 [US dollar (USD) 4,298.8] in 2012. The treatment and surgery fees were the largest contributor to direct medical costs (52.0%). The average direct medical costs of IHD patients insured by UEBMI were significantly higher than those insured by the URBMI [CNY 27,749.0 (USD 4,395.9) vs. CNY 21,057.7(USD 3,335.9), P < 0.05]. The direct medical costs and OOP expenses for all patients increased from 2008 to 2009, and then decreased during the period of 2009–2012. The time trends of direct medical costs between the UEBMI and URBMI patients were different during the period of 2008-2012. The regression analysis indicated that the UEBMI enrollees had higher direct medical costs (P < 0.001) but had lower OOP expenses (P < 0.001) than the URBMI enrollees. Male patients, patients having percutaneous coronary intervention operation and intensive care unit admission, patients treated in secondary hospitals and tertiary hospitals, patients with the LOS of 15–30 days, 30 days and longer had significantly higher direct medical costs and OOP expenses (all P < 0.001).ConclusionsThe direct medical costs and OOP expenses for patients with IHD in China were found to be high and varied between two medical insurance schemes. The type of insurance was significantly associated with direct medical costs and OOP expenses of IHD.

Value-based reimbursement programmes have become increasingly common in attempts to bend the cost curve of healthcare without negative effects on quality. The aim of this study was to analyse the effect of introducing a value-based reimbursement programme on the cost to third-party payer. We performed a retrospective observational study with a before and after design based on the introduction of a value-based reimbursement programme in Sweden. We analysed patient level cost data from inpatient and outpatient care of patients undergoing lumbar spine surgery, 2006–2015. The average 1-year episode cost decreased 11 percent during the first 2 years with the value-based reimbursement. The number of patients increased 22 percent during the same period, causing the total cost to increase by 8 percent. The value to third-party payer increased after the introduction of the value-based reimbursement since more patients were treated and attained a positive outcome. The decreased episode cost may be a result of better coordinated post-discharge care. Another explanation could be that costs previously borne by the third-party payer are shifted onto the healthcare providers. Thus, it is crucial that providers find a sustainable way of delivering care in the long term to retain value. Interlinking patient records facilitates a holistic perspective among healthcare providers raising awareness of health care utilization through the whole care chain.